4//SEC Filing
Pavesio Alessandra 4
Accession 0000899243-21-014846
CIK 0001665988other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:38 PM ET
Size
9.3 KB
Accession
0000899243-21-014846
Insider Transaction Report
Form 4
Pavesio Alessandra
SVP & Chief Science Officer
Transactions
- Award
Restricted Stock Units
2021-04-01+61,476→ 61,476 total→ Class A Common Stock (61,476 underlying) - Award
Stock Options
2021-04-01+4,900→ 4,900 totalExercise: $15.23Exp: 2031-03-31→ Class A Common Stock (4,900 underlying) - Purchase
Common Stock
2021-02-11$13.00/sh+1,000$13,000→ 1,000 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock units vest on April 1, 2022 and have no expiration date.
- [F3]The stock option vests in four equal annual installments beginning on April 1, 2022.
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0001835185
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:38 PM ET
- Size
- 9.3 KB